DO NOT reuse or share needles
Challenges and Future Directions of GLP-1 'Central Program' Intervention Current challenge: Individual differences and long-term safety Although GLP-1 injections have shown excellent efficacy in clinical trials, their "central plan" interventions still face challenges: Individual metabolic differences There are significant differences in the response of different patients to GLP-1RA, which are related to factors such as gene polymorphism, gut microbiota composition, and metabolic flexibility
White Trials have found that GLP-1 agonists are an effective tool for weight loss in highly controlled settings, often where patients also received structured weight-loss interventions, Gretchen E
So its no surprise that weight didnt change in any of the Eriomin studies
In clinical trials, participants experienced progressive weight loss over many months, with results continuing to improve as treatment continued
Honestly, I cant think of anything more they could do to help me get started and to make sure I got all my questions answered